These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30619253)

  • 21. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
    Conrad SM; Strauss-Ayali D; Field AE; Mack M; Mosser DM
    Infect Immun; 2007 Feb; 75(2):653-65. PubMed ID: 17088347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells: a trypanosome-released factor triggers interferon-gamma production that stimulates parasite growth.
    Olsson T; Bakhiet M; Edlund C; Höjeberg B; Van der Meide PH; Kristensson K
    Eur J Immunol; 1991 Oct; 21(10):2447-54. PubMed ID: 1915554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminazene aceturate resistance on the virulence of Trypanosoma brucei for rats.
    Egbe-Nwiyi TN; Igbokwe IO; Onyeyili PA
    J Comp Pathol; 2005 Nov; 133(4):286-8. PubMed ID: 16271938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.
    Vanloubbeeck Y; Jones DE
    Am J Trop Med Hyg; 2004 Oct; 71(4):407-11. PubMed ID: 15516635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma brucei infection protects mice against malaria.
    Sanches-Vaz M; Temporão A; Luis R; Nunes-Cabaço H; Mendes AM; Goellner S; Carvalho T; Figueiredo LM; Prudêncio M
    PLoS Pathog; 2019 Nov; 15(11):e1008145. PubMed ID: 31703103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeic acid combined with autoclaved Leishmania major boosted the protection of infected BALB/c mice by enhancing IgG2 production, IFN-γ/TGF-β and iNO synthase/arginase1 ratios, and the death of infected phagocytes.
    Belkhelfa-Slimani R; Djerdjouri B
    Inflammopharmacology; 2018 Apr; 26(2):621-634. PubMed ID: 28988279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of monoclonal antibodies for detecting T brucei brucei infection in splenectomised dogs.
    Egbe-Nwiyi TN; Antia RE
    J Small Anim Pract; 1995 May; 36(5):229-32. PubMed ID: 7650918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
    Belkaid Y; Von Stebut E; Mendez S; Lira R; Caler E; Bertholet S; Udey MC; Sacks D
    J Immunol; 2002 Apr; 168(8):3992-4000. PubMed ID: 11937556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sandfly Fever Sicilian Virus-Leishmania major co-infection modulates innate inflammatory response favoring myeloid cell infections and skin hyperinflammation.
    Heirwegh E; MacLean E; He J; Kamhawi S; Sagan SM; Olivier M
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009638. PubMed ID: 34310619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.
    Méndez S; Gurunathan S; Kamhawi S; Belkaid Y; Moga MA; Skeiky YA; Campos-Neto A; Reed S; Seder RA; Sacks D
    J Immunol; 2001 Apr; 166(8):5122-8. PubMed ID: 11290794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N; Lang T; Milon G; Antoine JC
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genital lesions in male red fronted gazelles (Gazella rufifrons) experimentally infected with Trypanosoma brucei and the effect of melarsamine hydrochloride (Cymelarsan®) and diminazene aceturate (Berenil®) in its treatment.
    Mbaya AW; Nwosu CO; Kumshe HA
    Theriogenology; 2011 Sep; 76(4):721-8. PubMed ID: 21601916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gammadelta T cells are not essential for control of cutaneous Leishmania major infection in genetically resistant C57BL/6 mice.
    Satoskar A; Okano M; David JR
    J Infect Dis; 1997 Dec; 176(6):1649-52. PubMed ID: 9395385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models.
    Solana JC; Ramírez L; Corvo L; de Oliveira CI; Barral-Netto M; Requena JM; Iborra S; Soto M
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005644. PubMed ID: 28558043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
    Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
    Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
    Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
    Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of an infection with Leishmania braziliensis confers complete protection to a subsequent challenge with Leishmania major in BALB/c mice.
    Lima HC; DeKrey GK; Titus RG
    Mem Inst Oswaldo Cruz; 1999; 94(1):71-6. PubMed ID: 10029914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Old World cutaneous leishmaniasis treatment response varies depending on parasite species, geographical location and development of secondary infection.
    Al-Salem WS; Solórzano C; Weedall GD; Dyer NA; Kelly-Hope L; Casas-Sánchez A; Alraey Y; Alyamani EJ; Halliday A; Balghonaim SM; Alsohibany KS; Alzeyadi Z; Alzahrani MH; Al-Shahrani AM; Assiri AM; Memish Z; Acosta-Serrano Á
    Parasit Vectors; 2019 May; 12(1):195. PubMed ID: 31046820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.